Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.00
Bid: 134.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.493%)
Open: 135.00
High: 135.00
Low: 135.00
Prev. Close: 135.00
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Sep 2020 12:20

RNS Number : 2009Z
Eurocell plc
16 September 2020
 

16 September 2020

 

Eurocell plc

 

Director/PDMR Shareholding

 

Eurocell plc (the "Company") announces that, on 9 September 2020, options were granted under the Eurocell plc Deferred Share Plan 2015 to 2 directors (in relation to the deferred element of the 2019 Annual bonus).

 

The notifications set out below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mark Kelly

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Grant of a nil-cost option to acquire shares under the Eurocell plc Deferred Share Plan 2015

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£nil (option price)

26,863

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A - single transaction

e)

Date of the transaction

9 September 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Michael Scott

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Grant of a nil-cost option to acquire shares under the Eurocell plc Deferred Share Plan 2015

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£nil (option price)

17,162

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A - single transaction

e)

Date of the transaction

9 September 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

For further information:

 

Eurocell plc 01773 842 100

Paul Walker

Group Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUMGBUPUGGQ
Date   Source Headline
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSNon-executive Directors' Share Purchase Plan
30th Jan 20247:04 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirectorate Change
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSLaunch of Share Buyback Programme
23rd Jan 20247:00 amRNSYear End Trading Update
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20234:30 pmRNSHolding(s) in Company
29th Nov 20234:30 pmRNSDirector/PDMR Shareholding
14th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:30 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20234:30 pmRNSDirector/PDMR Shareholding
16th Oct 20234:30 pmRNSHolding(s) in Company
13th Oct 20234:30 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSInvestor Presentation
21st Sep 20234:30 pmRNSDirector/PDMR Shareholding
7th Sep 20236:30 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Results
4th Sep 20237:00 amRNSBlock listing Interim Review
9th Aug 20234:30 pmRNSDirector/PDMR Shareholding
25th Jul 20237:00 amRNSTrading Update - In Line with Expectations
17th Jul 20237:00 amRNSHolding(s) in Company
18th May 20237:00 amRNSHolding(s) in Company
16th May 20234:00 pmRNSHolding(s) in Company
16th May 20237:00 amRNSHolding(s) in Company
15th May 20235:00 pmRNSChanges to Board Committee Memberships
12th May 20237:00 amRNSTrading Update and Board Changes
11th May 20234:30 pmRNSResult of AGM
10th May 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20237:00 amRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSInvestor Presentation
17th Mar 20237:00 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
7th Mar 20237:00 amRNSBlock listing Interim Review
3rd Feb 20237:00 amRNSNon-executive Directors' Share Purchase Plan
31st Jan 20237:00 amRNSHolding(s) in Company
26th Jan 20237:00 amRNSYear End Trading Update
6th Jan 20237:00 amRNSCEO Announces Intention to Retire in 2023
15th Nov 20227:04 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.